Among patients with asthma, blood eosinophil variability resulted in better identification of risk for hospital episodes compared with absolute counting values that are currently used to target specific asthma treatments.
“Despite the important relationship between asthma and eosinophil values, there is not clear evidence about eosinophil distribution in a nonsevere asthma cohort and in the general population in clinical practice or about their cutoff values to predict clinical outcomes or their variability over time,” Nuria Toledo-Pons, MD, from the department of respiratory